---
title: "Processa Pharmaceuticals, Inc. (PCSA.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/PCSA.US.md"
symbol: "PCSA.US"
name: "Processa Pharmaceuticals, Inc."
industry: "Pharmaceuticals"
---

# Processa Pharmaceuticals, Inc. (PCSA.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [www.processapharmaceuticals.com](https://www.processapharmaceuticals.com) |

## Company Profile

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drug...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.37 | 82/257 | - | - | - |
| PB | 0.82 | 36/257 | 2.29 | 1.40 | 0.78 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-09T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.10 |
| Highest Target | 25.00 |
| Lowest Target | 25.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/PCSA.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/PCSA.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/PCSA.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
